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Abstract
Background: Senescent cells are undesirable in cell therapy products due to reduced therapeutic activity and risk
of aberrant cellular effects, and methods for assessing senescence are needed. Early-passage mesenchymal stromal
cells (MSCs) are known to be small and spindle-shaped but become enlarged upon cell aging. Indeed, cell
morphology is routinely evaluated during MSC production using subjective methods. We have therefore explored
the possibility of utilizing automated imaging-based analysis of cell morphology in clinical cell manufacturing.
Methods: An imaging system was adopted for analyzing changes in cell morphology of bone marrow-derived
MSCs during long-term culture. Cells taken from the cultures at the desired passages were plated at low density for
imaging, representing morphological changes observed in the clinical-grade cultures. The manifestations of aging
and onset of senescence were monitored by population doubling numbers, expression of p16INK4a and p21Cip1/Waf1,
β-galactosidase activity, and telomeric terminal restriction fragment analysis.
Results: Cell area was the most statistically significant and practical parameter for describing morphological
changes, correlating with biochemical senescence markers. MSCs from passages 1 (p1) and 3 (p3) were remarkably
uniform in size, with cell areas between 1800 and 2500 μm2. At p5 the cells began to enlarge resulting in a 4.8-fold
increase at p6–9 as compared to p1. The expression of p16INK4a and activity of β-galactosidase had a strong
correlation with the increase in cell area, whereas the expression of p21Cip1/Waf1 reached its maximum at the onset
of growth arrest and subsequently decreased. Mean telomere length shortened at an apparently constant rate
during culture, from 8.2 ± 0.3 kbp at p1, reaching 6.08 ± 0.6 kbp at senescence.
Conclusions: Imaging analysis of cell morphology is a useful tool for evaluating aging in cell cultures throughout
the lifespan of MSCs. Our findings suggest that imaging analysis can reproducibly detect aging-related changes in
cell morphology in MSC cultures. These findings suggest that cell morphology is still a supreme measure of cell
quality and may be utilized to develop new noninvasive imaging-based methods to screen and quantitate aging in
clinical-grade cell cultures.
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Background
Mesenchymal stromal cells (MSCs) are intensively stud-
ied for use in advanced cell therapies. Because of their
strong immunosuppressive potential, MSCs have been
used to treat acute and chronic graft-versus-host disease
(GVHD) [1] and may prove beneficial for Crohn’s dis-
ease or other immunological disorders [2]. In addition to
their immunomodulatory properties, MSCs can differen-
tiate into osteogenic, adipogenic, and chondrogenic line-
ages [3], and therefore could be utilized in various tissue
regeneration applications [2].
MSCs are a small population of multipotent stromal
cells which can be isolated from various sources such as
bone marrow, adipose tissue, or umbilical cord blood
[4–7]. MSC cultures are heterogeneous, and only a sub-
population of the cells are self-renewing and may be
considered multipotent stem cells [8]. Clinical-grade
MSCs are commonly isolated from bone marrow aspi-
rates, where they comprise 0.001–0.01% of the mono-
nuclear cell fraction [9]. Because MSC therapies for
GVHD require a large number of cells, MSCs need to be
expanded extensively in vitro during production [2, 10].
Contrary to pluripotent stem cells, MSCs are somatic
cells with a limited lifespan [11, 12]. Aging of cultured
MSCs can be considered to begin when the primary cul-
ture has been established. Gradual aging leads finally to
senescence, where cell division is permanently arrested,
but the cells remain alive and metabolically active until
cell death [13, 14]. Replicative senescence is induced
through exhaustion of division potential, but senescence
may also be initiated by DNA damage or stressors such
as suboptimal culturing conditions [13, 15].
Telomeres shorten with each round of cell division and
reflect the biological age of cells and the organism [16].
Senescence is triggered when a cell’s shortest telomere has
reached its critical minimum length [17, 18]. In addition
to telomere shortening, aging and senescence are also ac-
companied by exhaustion of cell division [11], accumula-
tion of senescence-associated β-galactosidase (SA-β-gal)
[19], and an increase in expression of the cyclin-
dependent kinase inhibitor p16INK4a [20, 21], which is re-
sponsible for permanent cell cycle arrest together with the
p53/p21Cip1/Waf1 pathway [22]. However, the most readily
observed indicators of cellular senescence are changes in
cell size and morphology from small and spindle-shaped
into large and irregular cell shapes [12, 23].
Aging affects the functionality of cultured MSCs, ul-
timately leading to reduced differentiation [23] and im-
munosuppressive potential [24, 25], which are the
primary therapeutic mechanisms of MSCs in cellular
therapies. Senescence increases the risk of genetic in-
stability and cell transformation [26] but, importantly,
senescent cells affect their microenvironment by secret-
ing cytokines, chemokines, and proteases, known as the
senescence-associated secretory phenotype (SASP) [27,
28]. Cells with SASP have diverse effects including the
ability to promote tumorigenesis and facilitate prolifera-
tion and invasiveness of malignant cells [27].
Cells manufactured for therapeutic use must fulfill
high quality criteria. The International Society for Cellu-
lar Therapy (ISCT) minimal criteria for MSCs define
them as adherent fibroblastoid cells which express char-
acteristic surface antigens, lack hematopoietic markers,
and are able to differentiate into osteoblasts, adipocytes,
and chondroblasts [29]. For clinical-grade MSCs, quality
criteria also require sterility and normal karyotype [30].
Researchers and regulators agree that cell therapy
products should be evaluated for senescence because it
may compromise cell quality and functionality [26]. Sen-
escence and transformation are tightly connected, and
transformation is considered a serious safety risk of cell
therapies. However, it seems unlikely that genetic in-
stability of human MSCs will lead to transformation
[31–33], but rather the altered functions of the senescent
cells are a more likely risk to product quality and safety
[28]. Currently, there are a variety of methods available
for senescence assessment, but specific markers are still
lacking. Routine MSC manufacturing would benefit from
a robust and simple method for screening senescent cells
from cultures.
We have shown that MSCs of consistent quality
can be produced for clinical research programs [1,
10]. In this study, we have set up an analysis method
based on automated image analysis for quantification
of age-related changes in MSC morphology. We ana-
lyzed whether changes in morphology could be
quantified using an image analysis system, and how
these changes accompany cell aging. Our aim was to
establish and test the applicability of automated
image analysis to clinical-grade cell production as a
screening method for cellular senescence.
Methods
Bone marrow MSC cultures
MSCs were obtained from bone marrow aspirates taken
from the iliac crests of six healthy adult volunteer donors,
aged 20–40 years, after written informed consent. Donors
were coded for anonymity (MSC-1 to MSC-6). All donor
protocols were approved by the Ethical Committee of the
Hospital District of Helsinki and Uusimaa, Finland.
MSCs were isolated from bone marrow aspirates and
cultured continuously from passage p0 to senescence. For
this purpose, the cell culture was considered senescent if
the confluency remained less than 30% after 2 weeks of
culturing and cell appearance was typical of senescence,
i.e., large and flat cell morphology, irregular cell shapes
and granularity. MSCs were cultured in basic medium
consisting of Dulbecco’s modified Eagle’s medium
Oja et al. Stem Cell Research & Therapy  (2018) 9:6 Page 2 of 13
(DMEM) low glucose supplemented with 100 U/ml peni-
cillin, 100 μg/ml streptomycin (all from Life Technologies,
Thermo Fischer Scientific, Waltham, MA, USA), 40 IU/
ml heparin (Heparin LEO 5000 IE/KY/ml, Leo Pharma,
Malmö, Sweden), and 10% platelet lysate (Finnish Red
Cross Blood Service, named PL1 in Laitinen et al. 2015
[10]). Complete protocols for cell isolation and culturing
procedures are described elsewhere [10].
Continuous cultures were performed both on a small,
research laboratory scale (MSC-1 to MSC-3) and also
using large culture chambers (MSC-4 to MSC-6). For
small-scale cultures, 75 cm2 and 175 cm2 cell culture
flasks (Corning, NY, USA) were used, the 175 cm2 flask
being used at p1, p3, p5, p7, and p9 in order to obtain
sufficient cells for analyses. Large scale cultures were
performed using Cell Stack® (Corning) two-layer cell cul-
ture chambers with a growth area of 1272 cm2 to mimic
culturing vessels used in cell manufacturing. Cells were
collected for analyses at p1, p3, p5, and pSEN, the latter
representing the final collected passages (p6–9) where
cells were classified senescent as defined earlier.
Confluency and culture characteristics were monitored
during cell culturing by a Nikon Eclipse TS-100 phase
contrast and inverted microscope with 4× magnification
(Nikon, Japan). Upon reaching 80% confluency, the cells
were harvested using TrypLE Select CTS (Invitrogen,
MA, USA). Cell count and viability were measured using
NucleoCounter (Chemometec, Denmark) and cells were
reseeded at a density of 1000 cells/cm2 and passaged
continuously until senescent.
Population doubling (PD) was calculated for each pas-
sage according to PD = log2 (NH/N1), where N1 is the
number of seeded cells/cm2 (starting count), and NH is
the number of harvested cells/cm2. The CFU-F count of
the original bone marrow aspirate at passage 0 was used
as the first N1 [10]. The successive PDs obtained at each
passage were added together to obtain the cumulative
PD number for a continuous culture.
Characterization of the MSCs
Characterization of the MSCs was performed according
to ISCT guidelines [29]. Flow cytometric analysis of the
cell surface antigens CD44, CD49e, CD13, CD90, CD73,
CD29, CD105, CD14, CD19, CD34, CD45, HLA-ABC,
and HLA-DR was performed using the Navios Cyt-
ometer (Beckmann Coulter, IN, USA) and analyzed
using FlowJo software (version 7.4.1, Tree Star Inc., CA,
USA). At least 5000 cells were analyzed per sample. All
antibodies were purchased from BD Biosciences (CA,
USA), except HLA-DR IgG1 isotype control, which was
from Abcam (UK).
For osteogenic and adipogenic differentiation assays
MSCs were plated at a density of 1000 cells/cm2 in six-
well plates and cultured to confluency in basic medium.
Osteogenic and adipogenic differentiation assays were per-
formed according to Laitinen et al. [10]. Osteogenic differ-
entiation was detected by von Kossa staining [34–38], and
adipogenic differentiation by Sudan III staining [36–38].
Sample preparation for the image analysis
The cells from passages 1, 3, 5, and SEN (passages 6–9)
were plated at 3000 cells/cm2 on six-well plates for sub-
sequent fixation and staining. After attachment and
spreading for 48 h, the cells were fixed with 4% parafor-
maldehyde (Sigma, MO, USA) and stored at 4 °C in
0.02% sodium azide/phosphate-buffered saline (PBS).
Fixed cells were permeabilized with 0.1% Triton X-100/
PBS (Sigma), and the cytoplasm was stained using Cell
Mask Deep Red Stain (1 μg/ml, Life Technologies) and
the nuclei with DAPI (0.125 μg/ml, Sigma).
Image calibration and acquisition settings
For calibration purposes, a range of several test MSCs of
different passages was plated, fixed, and imaged as de-
scribed in the previous paragraph. Calibration data were
analyzed several times from each sample, and gating pa-
rameters were adjusted manually after each iteration.
These parameters were the minimum object size, the
threshold signal intensity when two objects are consid-
ered separate, and the threshold for finding an object’s
edge. An object was considered a cell when it included
only one nucleus and it was wholly contained within the
image field (Fig. 1a-d). The program was also instructed
to accept only objects that were larger than a set size
limit, 765 μm2. This resulted in a final imaging protocol
yielding only a few false positives, i.e., low proportion of
cell culture debris being classified as viable cells or two
cells counted as one, and a moderate level of false nega-
tives (viable cells gated out). We found that it was neces-
sary to adjust the exposure time separately for each run
because of dye bleaching. Adjustment was performed
automatically using the first field of each run. The image
was automatically refocused after every ten fields, result-
ing in reasonable image quality and running time.
Image acquisition
The images were acquired using a high-content screen-
ing microscope (Cell Insight, Thermo Scientific, IL,
USA) with a 10× objective (Olympus, Japan). Signals
from Cell Mask and DAPI stains were acquired on sep-
arate channels using filters at 630 nm and 386 nm, re-
spectively. Three to six wells of a six-well plate were
imaged for each analysis resulting in 999–1998 images
per channel at each run. The images were taken starting
from the well center in a spiral fashion to minimize the
optical distortion caused by the convexity of the well
bottom near the edges.
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Image analysis
The resulting images were analyzed using Cell Omics
Morphology Explorer software (version V4, Thermo Sci-
entific). Altogether nine morphological parameters were
measured for every cell; four for size (length, width, area,
and perimeter) and five for shape (perimeter to area ratio,
length to width ratio, boxed frame ratio, convex hull area
ratio, convex hull perimeter ratio) (Table 1). Boxed frame
ratio refers to the cell area, which is defined by fitting a
cell inside a rectangular box after which the ratio of the
cell area to the bounding box area was calculated. Convex
hull was defined by stretching an imaginary rubber band
around the cell and calculating the area demarcated by
the rubber band. Convex hull area ratio was determined
by calculating the ratio of rubber band framing area to the
cell area calculated according to cytoplasmic stain.
Telomere length analysis
Mean telomere lengths were measured by Southern blot
analysis of terminal restriction fragments (TRFs) [39].
Genomic DNA from snap-frozen cell pellets was purified
using the Qiagen DNeasy Blood and Tissue Kit (Qiagen,
MD, USA) and precipitated with sodium acetate and
ethanol. The integrity of the purified DNA was evaluated
by electrophoresis on a 1% agarose gel. Telomere length
analysis was performed from triplicate samples using a
TeloTAGGG Telomere Length Assay Kit (Roche,
Switzerland). Extracted genomic DNA (2 μg) was
digested using RsaI and HinfI enzymes and electropho-
resed on a 0.8% agarose gel 125 V (4 V/cm) for 4.5 h.
The separated DNA was transferred to a positively
charged nylon membrane (Roche, Switzerland) by
Southern blotting using 20× saline-sodium citrate buffer
(SSC), after which the transferred DNA was UV-
crosslinked at 120 μJ/cm2 (UVP CL-100, UK). The blot
was hybridized overnight with a digoxigenin (DIG)-la-
beled telomere-specific probe (TTAGGG), which was
subsequently detected using an alkaline phosphatase-
labeled anti-DIG antibody and CDP-Star chemilumines-
cent substrate and used to expose an autoradiography
Fig. 1 Automated Cell Insight analysis (representative figures). The images were acquired from passages p1, 3, 5, and pSEN (a–d) from six donors
using 10× magnification. The cell nuclei and the cytoplasm were stained with DAPI and Cell Mask Deep Red Stain, respectively. Cells accepted for
the analysis are lined in green and excluded cells in magenta
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film (GE Healthcare, WI, USA). The average length
(kilobase pairs, kbp) of the telomeric TRFs were calcu-
lated using ImageJ analysis software [40] and Excel soft-
ware (Microsoft, WA, USA) according to mean TRF = Σ
(ODi × Li)/Σ (ODi) where ODi is optical density and Li is
the length of the TRF at position i. TRF signals between
3 and 20 kbp were used for telomere length measure-
ments [39].
Immunoblotting of the cell cycle regulatory proteins
Snap-frozen cell pellets were lysed in RIPA buffer
(Thermo Scientific) containing 1% (v/v) Protease Inhibi-
tor Cocktail (Sigma). Protein concentrations were deter-
mined using the BCA Protein Assay Kit (Pierce, IL,
USA); 20 μg of total protein was run on a 12% TGX gel
(Bio-Rad, CA, USA) and electrotransferred to a Hybond
ECL nitrocellulose membrane (GE Healthcare). The
membrane was blocked with 5% milk in TBST and
immunoblotted using anti-p16INK4a (1:500; clone G175-
1239) and anti-p21Cip1/Waf1 (1:250; Clone SXM30) (both
BD Pharmingen, CA, USA) primary antibodies. β-Actin
(1:8000; monoclonal anti-β-actin, clone AC-74; Sigma)
was used as a loading control. Horseradish peroxidase
(HRP)-conjugated polyclonal anti-mouse immunoglobu-
lin was used as the secondary antibody (1:1000; Dako
Cytomation, Denmark). The signal was detected using a
chemiluminescent detection system (ECL; GE Health-
care), and the band intensities were quantified using a
Scanjet G4050 scanner (Hewlett-Packard, CA, USA) and
Image J analysis software [40].
Senescence-associated β-galactosidase assay
SA-β-gal activity was measured using the Cellular Senes-
cence Assay Kit (Cell Biolabs, CA, USA) according to
the manufacturer’s instructions. Cells for the assay were
cultured until 80% confluency and samples were col-
lected. Samples were lysed, and equal amounts of total
protein were loaded to the assay. Fluorescent signals
were read using a ClarioStar monochromator plate
reader (BMG Labtech, Germany) with excitation at
360 nm and emission at 465 nm.
Statistical analysis
The statistical analysis of the data was performed using
Mathematica software (version 11.0.1, Wolfram Research,
IL, USA). The imaging data were cleaned by removing
outliers and by applying the Box-Cox transformation. The
outlier removal was performed by trimming out a portion
of the smallest and largest values of the corresponding
variable. The Box-Cox transformation for a variable y with
a parameter λ is of the form y’ = (yλ-1)/λ if λ ≠ 0, and y’ =
log(y’) if λ = 0. Analysis of variance (ANOVA) tests were
used, one- and two-way, for analyzing the group differ-
ences. If differences were statistically significant with more
than 95% confidence, paired differences between the
groups were tested with Bonferroni-corrected Student’s t
tests. The two-sample Kolmogorov-Smirnov distribution
test was used to test the hypothesis of two distributions
being the same for the data in Fig. 3.
Correlation analyses between mean cell area measure-
ments after outlier removal and aging-related markers
were performed by determining Pearson correlation co-
efficients. Visualization of the correlations was done by a
heat map and principal component analysis using R lan-
guage for statistical programming and graphical analysis.
Results
Characterization of MSCs
MSCs were characterized by immunophenotype, adher-
ence to plastic, and by the ability to differentiate into
osteogenic and adipogenic lineages. Samples from all do-
nors expressed the surface antigens CD13, CD44,
CD49e, CD90, CD73, CD29, CD105, and HLA-ABC,
and were negative for CD14, CD19, CD34, and CD45
(Additional file 1: Table S1). In distinction from ISCT
guidelines [29], the cells from all donors expressed
HLA-DR (average 27.1% positive cells, range 7.5–47.4%)
as we have reported previously for cells grown in platelet
lysate [10]. All cells differentiated into osteogenic and
adipogenic lineages (Additional file 2: Figure S1 and
Additional file 3: Figure S2).
Growth kinetics
Average culturing time for MSC-1 to MSC-6 from pri-
mary cultures to senescence was 80 ± 10 days (Fig. 2a).
Table 1 Parameters with explanations acquired using
automated image analysis
Size
Length Length of image-aligned bounding box of cell
Width Width of image-aligned bounding box of cell
Area Area of the cell
Perimeter Perimeter of the cell
Shape
Perimeter to area
ratio
The ratio of the cell perimeter to 4π area of the
cell. A measure of the roundness of the cell.
Length to width
ratio
The ratio of the length and width of the
bounding box of the cell.
Boxed frame ratio The ratio of the cell area to the bounding box
area.
Convex hull area
ratio
Ratio of convex hull (“rubber band bounding the
cell”) area to the cell area. Convex hull area ratio
is greater in cells with long pointy processes
compared to cells with no sharply shaped
processes.
Convex hull
perimeter ratio
The ratio of convex hull length to the detected
cell edge length.
Altogether nine parameters describing cell morphology were measured using
the Cell Insight platform
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Cells from almost all donors were in logarithmic growth
phase (average 0.85 PD/day) until passages 5–6, after which
the rate of cell population doubling decreased to 0.31–0.82
doublings/day (Fig. 2b). The cultures ceased proliferation at
passages p5–p9 after 38.5 ± 5.6 PDs. Division of donor
MSC-2 cells was arrested early, after 25 PDs at passage 5.
Also, donor MSC-3 cells showed earlier exhaustion of div-
ision potential. MSCs from the first passages (p1–3) were
small and spindle-shaped, whereas cells from passage 5
manifested changes in morphology (Fig. 2c). The pSEN
passages (the final collected passages, p6–9) showed typical
characteristics of senescent cells such as large size, irregular
shapes, and granularity (Fig. 2c).
Statistical analysis of cell morphology
Image analysis of cells produced morphology for a total
of 313,141 cells. It is evident that this large dataset con-
tains cases that the automated image analysis system has
misinterpreted, e.g., classifying overlapping cells as one
or debris as whole cells. Therefore, the data were
trimmed before the actual analysis to remove artificial
outlier values. We selected to trim out 5% of the smal-
lest and largest values. As a consequence, the total num-
ber of cells for the analysis was 281,827.
Even after the outlier removal, the morphological vari-
able distributions were remarkably non-normal. Almost
all the distributions were highly skewed to the right, ex-
cept the boxed frame ratio and the convex hull perimeter
ratio, which were skewed to the left. For example, the
average skewness value for the cell area was 0.96 over the
donor/passage groups. Therefore, the Box-Cox transform-
ation with λ = 0 (log-transform) was applied to all the
variables, except for the boxed frame ratio and the convex
hull perimeter ratio variables, for which λ = 2 transform
was performed. After the transform, the variable distribu-
tions were closer to normal, and the average skewness for
the transformed cell area, for example, was 0.091.
In order to select the best morphological variable associ-
ated with the PD number, we fitted linear first-degree
models with each morphological variable as the explanatory
variable for the PD. Furthermore, we tested both the
donor/passage subgroup mean value and the standard devi-
ation (SD) value as the explanatory variable. The R2 coeffi-
cient of determination for the models was highest for the
variables describing the size of the cell, i.e., area, perimeter,
length, and width. Also, the SD of the group gave higher R2
values than the mean of the group. For the SD of the size
variables, the R2 values were 48% for the area, 47% for
length, 43% for perimeter, and 38% for width. Thus, we
conclude that the cell area or the uniformness of the cell
area is the best indicator of the increasing PD numbers.
To statistically verify that there are significant differ-
ences in cell area between the passages, we analyzed the
donor/passage groups using a two-way ANOVA test. For
the cell area, the result showed that donors, passages,
and donor/passage groups all had non-constant cell area
values with p values practically zero. Furthermore, the
pairwise post-tests showed that all the donor-donor or
passage-passage differences are statistically significant.
Extended in vitro culture is associated with an increase in
cell size
We then systematically analyzed cell area and its distri-
bution in continuous MSC cultures. Passage 1 MSCs
Fig. 2 Growth kinetics from long-term continuous cultures of MSCs. Mesenchymal stromal cells (MSCs) were isolated from bone marrow aspirates
collected from healthy volunteer donors (n = 6; MSC-1 to MSC-6) and cultured continuously from primary cultures (passage 0) to senescence.
a Cumulative population doubling numbers (PD) are presented as a function of culturing time. Each point in the growth curve indicates an individual
cell passaging event starting from passage 0. b The rate of cell division is presented as PD/culturing day per passage (n = 6). c Representative
morphology and culture characteristics of long-term MSC cultures from passages 1, 3, 5, 7, and 9 (donor MSC-6) imaged using 4× magnification. The
respective passage (p) numbers are shown in each micrograph
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were a homogenous population of small cells (Fig. 3a).
During further culture, the distribution of cell sizes was
broadened towards the right, slightly at passage 3 and
markedly at passage 5 and onwards (Fig. 3a and b).
Nevertheless, a population of small cells could be de-
tected even at pSEN passages (Fig. 3a). The mean cell
area at passage 1 (19.3 ± 1.5 PD) was 1827 ± 329 μm2
(Fig. 4a and b, Table 2). A moderate increase in cell area
was seen at passage 3 (28.3 ± 2.1 PD) with an average of
2352 ± 386 μm2, and further at passage p5 (33.5 PD)
resulting in cell areas of 4198 ± 1628 μm2. The average
cell size increased remarkably at pSEN when cell areas
were 4.8-fold higher compared to passage 1 with cell
areas of 8744 ± 2494 μm2 (Table 2). Maximum PD num-
bers at pSEN were 36.6 ± 7.1. The increase in cell size is
particularly abrupt when plotted against PD numbers,
reflecting the slowing of population growth at late pas-
sages (Fig. 4a). However, a marked escalation of cell gain
upon senescence is also noted when cell size is plotted
against passage number (Fig. 4b). Different cultures dis-
played the sharp escalation in cell size at different PDs,
reflecting the variability at which the cultures reached
senescence. The cells that were grown in small-scale cul-
ture flasks reached a larger size (10,368 ± 1013 μm2) at
final passages than cells grown in large-scale vessels
(6306 ± 1739 μm2) (Additional file 4: Figure S3). How-
ever, in both culture formats, a pronounced increase in
cell area at final passages could be observed.
Increase in cell size is accompanied by the expression of
senescence markers
Cellular aging and senescence were characterized by
Western blot analysis of the cyclin-dependent kinase in-
hibitors p16INK4a and p21Cip1/Waf1, quantitative analysis
of SA-β-gal activity, and telomere length analysis (Fig. 5).
The expression of the cell cycle regulatory protein
p16INK4a at passages 1 and 3 was low but was markedly
increased at passage 5 (33.5 ± 4.7 PD), average 19,5-fold
compared to p1 (see Additional file 5: Figure S4). Maximal
expression of p16INK4a was seen at passages 6–7 (35.8 ±
5.9 to 40.5 ± 4.0 PD) (n = 5), with a 33-fold expression as
compared to p1 (Fig. 5a; Additional file 5: Figure S4).
Fig. 3 Mean cell area variability in MSCs. Representative graphs of the size distributions of MSCs according to a cell area and b log cell area,
acquired from filtered data. Maximum value in y-axis (probability) for passage p5 and senescent passage pSEN graphs was set lower than in
passage p1 and 3 graphs for better visualization of the size distribution. The two-sample Kolmogorov-Smirnov test was used to verify the similarity
between the distributions for passage 1 against the passages 3, 5, and SEN. The p values were all well below any sensible rejection limits, starting
from 1.4 × 10–5 for the passage 3 distributions. Thus, we can safely reject the hypothesis that the distributions between the passages would be
the same. The non-parametric Kolmogorov-Smirnov test will give the same p values for the original (a) and the log-transformed (b) distributions
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Expression of p21Cip1/Waf1 remained moderate from
passage 1 to pSEN, with a small increase seen after
passage 3, but with diminished expression at passage
5 when p16INK4a reached its maximum and cells
entered senescence.
The mean telomere length was assessed using TRF
analysis (Fig. 5c and d; Additional file 6: Figure S5).
Telomeres shortened with a constant rate from passage
1 to pSEN for all donor-specific MSCs. Mean telomere
length at passage 1 (19.3 ± 1.5 PD) was 8.2 ± 0.3 kbp
(range 7.7–8.5 kbp) and 7.7 ± 0.5 kbp (range 7.0–8.2
kbp) at passage 3 (28.3 ± 2.1 PD). The mean telomere
length at pSEN (36.6 ± 7.1 PD) was 6.8 ± 0.6 kbp (range
6.1–7.8 kbp). The average rate of telomere shortening
was 36.1 ± 12.4 bp/PD (range 23.9–56.3 bp/PD).
Correlations between changes in the different aging-
related parameters were analyzed by determining Pear-
son correlation coefficients between cell area and each
aging-related marker (Table 3 and Fig. 6a). There were
strong positive correlations (denoted by red circles in
Fig. 6a) between cell area and p16INK4a and between cell
area and β-galactosidase, and strong negative correla-
tions (shown as blue circles in Fig. 6a) between cell area
and PD/day (pace of proliferation), and between cell area
and shortening of mean telomere length. Changes in the
expression of p21Cip1/Waf1 correlated weakly with the
changes in cell size (Table 3 and Fig. 6a). Principal com-
ponent (PC) analysis (Fig. 6b) visualized the correlations
presented in Table 3 and Fig. 6a, showing strong inter-
dependence between the expression of p16INK4a and SA-
β-gal and between PD/day and telomere length (oblique
rotations). The expression of p21Cip1/Waf1 differed
strongly along the PC2 axis from the other variables, in-
dicating weak correlation with the increase in cell area
(orthogonal rotation).
Discussion
Monitoring cell morphology is an essential part of
clinical-grade MSC manufacturing [30]. However, simple
methods for objective quantitation of changes in cell
morphology during MSC culture are lacking. Aged and
senescent cells should be avoided in clinical-grade cell
cultures because they may compromise product quality
and safety. Hence, methods for assessing the proportion
of aged cells within MSC cultures are needed. In this
study, we explored the use of an imaging analysis system
for detecting aging-related changes in MSC cultures. We
cultured MSCs from bone marrow aspirates of six
healthy volunteer donors in animal serum-free culture
conditions and measured the exact sizes of MSCs during
long-term culture. We studied the correlations of mor-
phological changes with senescence-associated parame-
ters such as expression of the cyclin-dependent kinase
inhibitors p16INK4a and p21Cip1/Waf1, the activity of
SA-β-gal, and shortening of mean telomere length.
Fig. 4 Mean cell area increases with extended in vitro cell culture. Mean cell area is presented in function of a population doubling (PD) numbers
and b passages after outlier filtering (n = 6). Each point in the graph presents imaged passages 1, 3, 5 or p6–9 (pSEN). Standard deviations are
omitted from the graph for clarity
Table 2 Mean cell areas, corresponding population doubling numbers, and fold-changes in comparison to passage 1
Population doubling (passage) Mean cell area (μm2) Fold-change in cell area in comparison to passage 1
19.3 ± 1.5 (p1, n = 6) 1827 ± 329
28.3 ± 2.1 (p3, n = 6) 2352 ± 386 1.3
33.5 ± 4.7 (p5, n = 6) 4198 ± 1628 2.3
36.6 ± 7.1 (pSEN, n = 5) 8744 ± 2494 4.8
Measurements from passages (p)1, 3, and 5 are performed from all six donors. Morphological analysis of passages 6–9 (pSEN) were acquired from n = 5 due to
early senescence of donor MSC-2 cells
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The Cell Insight platform met our requirements for auto-
mated imaging analysis with readouts of several morpho-
metric parameters. It is a high-content screening system for
automated fluorescence image acquisition and quantitative
analysis. As the ultimate goal was to test the applicability of
the screening system in MSC manufacturing, we chose to
use a conventional six-well culture plate format for imaging
instead of, for example, small format glass-bottomed or
coated plates that are considered optimal for imaging appli-
cations. This strategy might increase autofocus failures but,
on the other hand, it better mimics culturing conditions for
the MSCs. The six-well format also allowed us to avoid well
edges in order to collect imaging data only from areas con-
taining cells without distortions.
This study addresses three questions: 1) is it possible to
quantify changes in cell morphology during long-term cul-
ture; 2) which is the most useful morphometric parameter
for assessing cell aging; and 3) do the observed morpho-
logical changes correlate with the expression of senescence
markers. Our aim was to test if aging-related morphological
changes could be detected and quantified using an auto-
mated imaging analysis and to explore the use of such a
method during the production of clinical-grade MSCs.
Cells from the first passages are uniform in size
The major finding in this work was that cells from the
first culture passages (p1 and p3) were remarkably uni-
form in size, correlating with low expression of
Fig. 5 The expression of aging-related markers is increased at the onset of senescence. a A representative image of p16INK4a and p21Cip1/Waf1
Western blot analyses (n = 6). Equal amounts of total protein (20 μg) were loaded onto the gel, and β-actin was used as a loading control.
b Senescence-associated β-galactosidase (SA-β-gal) activity was measured from three donors using a quantitative activity assay. Equal amounts of
total protein were used per sample, and all samples were analyzed in triplicate. The results are presented as relative fluorometric units (RFU).
Bonferroni-corrected Student’s t test, ***p < 0.001. Mean telomere length was measured from six donors using terminal restriction fragment
analysis (TRF) and presented as in function of c population doubling (PD) numbers and d passage. Mean telomere length is shown as kilobase
pairs (kbp)
Table 3 Pearson correlation coefficients determined for mean cell area and each aging-related marker
Mean cell area PD/day p16INK4a p21Cip1/Waf1 SA-β-gal Mean telomere length
Mean cell area 1.00 −0.74 0.50 0.52 0.70 -0.71
PD/day −0.74 1.00 −0.59 −0.67 -0.80 0.89
p16INK4a 0.50 −0.59 1.00 0.52 0.66 -0.36
p21Cip1/Waf1 0.52 −0.67 0.52 1.00 0.23 -0.63
SA-β-gal 0.70 −0.80 0.66 0.23 1.00 -0.65
Mean telomere length −0.71 0.89 −0.36 −0.63 -0.65 1.00
The data were collected from long-term cultures of three donors
PD population doubling, SA-β-gal senescence-associated β-galactosidase
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senescence markers and a rapid logarithmic growth
phase. The mean cell area and its variation began to in-
crease rapidly after passage 5 (33.5 ± 4.7 PD), coincident
with a significant increase in the expression of p16INK4a
and SA-β-gal (Fig. 5a; Additional file 5: Figure S4 and
Additional file 6: Figure S5B). Expression of p21Cip1/Waf1
was moderately elevated during passages 3–5, before
maximal expression of p16INK4a was reached, and de-
creased when p16INK4a expression attained its maximum
(Fig. 5a; Additional file 5: Figure S4). Similar changes co-
incident with the onset of the senescence process and
have also been reported by others [22].
The cell cultures of the study were performed both in
small-scale culture flasks as well as in large two-layer
cell stacks (1272 cm2), the latter mimicking the culture
vessels used in clinical-grade manufacturing. Although
the final cell area attained by the cells in the small-scale
was larger than in large-scale cultures (Additional file 4:
Figure S3), the phenomenon of abrupt area increase
upon senescence was identical in both culture formats.
No differences in senescence marker expression were
observed either, suggesting that cell area monitoring can
be applied to many types of cell culture systems.
We observed a conspicuously early increase in mean
cell area with donor MSC-2 cells at p5. Cell proliferation
likewise arrested early, after 25 PDs. Early exhaustion of
division potential is most likely connected to donor age:
the other donors were 20–30 years old, whereas donor
MSC-2 was 40 years of age. Similar findings correlating
higher donor age with lower proliferative capacity have
been reported by others [41, 42]. These results demon-
strate that an increased cell size rather than PD number
could indeed serve as a useful indicator of unanticipated
senescence in MSC cultures.
A number of studies have correlated MSC morphology
with proliferation or differentiation potential. Mets and
Verdonk showed that a population of MSCs consisted of
two types of cells, which could be separated by their size
and proliferative capacity [12]. These findings were com-
plemented by identification of very small and rapidly
replicating MSCs, with divergent surface epitopes and
high differentiation potential [5]. Automated microscopy
and image analysis tools that resembled our setup have
also been applied to MSC cultures in other studies [43–
45]. Whitfield and colleagues [43] imaged MSCs con-
tinuously over 6 days and were able to form lineage
maps arising from single cells to describe the onset of
heterogeneity in MSC populations. They defined
7000 μm2 as a threshold area for large cells and found
all such cells to be β-galactosidase positive. In our study,
large cell sizes, 8744 ± 2494 μm2, were found among
pSEN (passages 6–9) cells and the highest SA-β-gal ac-
tivity was detected at passage 7 and thereafter.
The morphology of MSCs is highly predictive of their
mineralization and immunosuppressive capacities [44,
45]. Small size, high colony-forming unit capacity and
high proliferation rates were associated with a lower rate
of telomere shortening in another study, which de-
scribed predictive characteristics for MSC potency [46].
Measurement of cellular thickness using atomic force
microscopy (AFM) can be used to analyze cell size to
discover the relation of cell shape to the proliferative po-
tential. Katsube and colleagues [47] found MSCs with
high proliferative capacity to be thick, but became thin
Fig. 6 The expression of aging-related markers correlates with the increase in cell area. a Pearson correlation coefficients were determined to
study the correlations between senescence markers and changes in cell size. Correlations are presented as a heat map, where red circles represent
positive and blue circles negative correlations between senescence markers and cell area. The size of the circle indicates the value of the Pearson
correlation coefficient. b Principal component analysis (PCA) was used to visualize the directions between the correlations in the mean cell area
and the expression of aging-related markers. The PC1 axis aligns with mean cell area (positive) and population doublings (PD) per day (negative),
and the mean telomere length, p16INK4a, and SA-β-gal variability also correlate with this axis. The PC2 axis is orthogonal to PC1, and mostly
describes the variability in p21Cip1/Waf1 without a strong correlation to the mean cell area
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when the capacity was lost. Cells with low proliferative
capacity were reported to be β-galactosidase positive and
expressing elevated levels of the senescence-associated
genes p16INK4a, p21Cip1/Waf1, and MMP-1. Although
AFM is an ideal method for measuring cellular thick-
ness, its usefulness is limited due to the technical com-
plexity and its tendency to cause cell damage.
Telomeres shorten at a constant rate during MSC culture
Mean telomere lengths were measured using TRF analysis.
Starting from 8.2 ± 0.3 kbp at p1, the telomeres of cells
collected at pSEN had been trimmed down to 6.8 ± 0.6
kbp in length, shortening at an approximately constant
rate of 36.1 ± 12.4 bp at each cell division. No clear thresh-
old value for telomere length regarding the onset of senes-
cence could be observed. A more precise correlation of
telomere shortening and senescence may require quantify-
ing the length of the shortest instead of the average telo-
mere length in the cells, which is known to trigger
replicative senescence [17, 48]. However, our results con-
firm that telomere shortening occurs during long-term
MSC expansion as part of the cellular aging process.
Expression of aging-related markers correlates with the
increase in cell size
Correlation analysis visualized by a heat map and PC
analysis revealed the interdependence between changes
in the cell area and the manifestation of senescence-
related markers. The positive correlations between mean
cell area and increasing expression of p16INK4a and SA-
β-gal as well as negative correlations between cell area,
ceasing proliferative capacity, and decreasing telomere
length confirmed that screening of enlargement of cell
size does indeed indicate the expression of senescence-
related markers. An initial increase and late decrease in
the expression of p21Cip1/Waf1 combined with the expres-
sion of p16INK4a is typical of cells with replicative senes-
cence, and has also been reported by others [21, 22].
Senescence assessment as a part of quality control
Senescence is, on the one hand, an essential tumor sup-
pressive mechanism, but on the other hand detrimental
to the cell itself and its surroundings. Researchers and
regulators agree that assessment of senescence should be
included in the quality control of cell therapy products
[2, 26, 30, 32]. Quality control testing depends on the
clinical application, but must include tests for purity,
identity, and potency, for example. For MSCs this in-
cludes at least sterility tests, karyotype analysis, and tests
to verify fulfilled ISCT minimal criteria [29] and func-
tional properties such as immunosuppressive capacity
[49]. The use of passage numbers to describe cellular
age is questionable due to variable plating densities and
harvesting practices, and therefore population doubling
numbers are a more suitable measure for cellular age.
However, our study suggests that MSC cultures grown
under identical conditions vary in their proliferation po-
tential and onset of the aging process. Thus, absolute
PD limits to define good-quality MSCs are of limited
value as quality criteria, and passage numbers are even
less suitable. On the other hand, each cell product
should be screened for its content of senescent cells to
determine its quality.
Detection of senescence-associated DNA methylation
changes provides an accurate assessment of the extent of
senescence and can be used to evaluate the cell product,
but the methodology is cumbersome [30, 50]. Phase-
contrast microscopes qualified for documentation com-
bined with supervised machine learning applications
could, however, be a labor-saving and cost-effective option
to screen MSC cultures [51, 52] once a prediction model
has been established. From the regulators’ point of view,
the use of senescence tests are not currently considered
mandatory for the release of cell batches. However, they
emphasize the need for manufacturers to assess the mani-
festations of senescence in their product [26].
Future prospects in using imaging technology in cell
manufacturing process
Methods to separate MSCs with different morphologies have
concentrated on flow cytometry and imaging-based methods,
which allow the exact quantification of the cell area and
other morphological parameters. Imaging applications with
machine learning analysis and prediction models have
already been successfully applied in biological studies [42–45,
52] and may also be utilized in clinical-grade cell manufac-
turing [53, 54]. Our results show that imaging analysis is able
to detect aging in MSC cultures; aging-related increase in cell
area can be easily and reproducibly detected. A variety of
methods are available for imaging applications, but most
methods, such as ours, require sample collection, fixation,
and staining steps which are difficult to integrate into the
manufacturing process. Label-free imaging in combination
with machine learning methods [53] could provide the ideal
combination for integrating noninvasive real-time morpho-
logical image analysis into routine cell manufacturing.
Conclusions
In this study, we quantified changes in cell morphology
in long-term MSC cultures and found that cell area is
the most significant and practical parameter to describe
the morphological changes that accompany cell aging.
We also showed that cell area correlates with the mani-
festation of senescence-associated markers. We conclude
that image analysis is able to detect aging-related
changes in cell morphology and can be applied in
clinical-grade manufacturing and can thus provide a ro-
bust tool for MSC quality control.
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Additional files
Additional file 1: Table S1. Surface antigen expression of the MSCs. All cells
(n= 6) expressed typical surface antigens of MSCs. In distinction to ISCT minimal
criteria, MSCs expressed variable levels of HLA-DR antigen. (DOCX 13 kb)
Additional file 2: Figure S1. Osteogenic differentiation of the MSCs.
MSCs from six donors differentiated into osteoblasts. A) 100% confluent
undifferentiated control cells for osteogenic differentiation. B) Mineralization
was detected by von Kossa staining in MSCs differentiated to osteoblasts.
Images were acquired using 10× magnification. (PDF 162 kb)
Additional file 3: Figure S2. Adipogenic differentiation of the MSCs.
MSCs from six donors differentiated into adipocytes. A) 100% confluent
undifferentiated control cells for adipogenic differentiation. B) Adipogenic
differentiation was detected by Sudan III staining. Images were acquired
using 4× and 10× magnifications. (PDF 160 kb)
Additional file 4: Figure S3. Mean cell area in small-scale and large-
scale long-term cultures. Long-term cultures of MSCs were performed in
small-scale in culture flasks (n = 3) and in large-scale (n = 3) in two-layer
cell stacks. Bonferroni-corrected Student’s t test, **p < 0.01; ANOVA, *p <
0.05; ns not significant. (PDF 33 kb)
Additional file 5: Figure S4. Western blot analysis of aging-related ex-
pression of p16INK4a and p21Cip1/Waf1. Western blot analysis was per-
formed from cell lysate samples containing 20 μg total protein for six
donors. β-actin was used as a loading control. (PDF 59 kb)
Additional file 6: Figure S5. Telomere length measurement using TRF
analysis. A representative figure of the measurement of the mean
telomere length. The measurement was performed for MSC-1 to MSC-6
(n = 6). Each sample was analyzed in triplicate and mean telomere length
was calculated according to [39]. (PDF 40 kb)
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